Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Advani, AS; Tse, W; Jia, X; Elson, P; Cooper, B; Ali-Osman, F; Park, J; Rao, AV; Rizzieri, DA; Wang, ES; Cotta, CV; Kalaycio, M; Sobecks, RM; Rouphail, B; Maciejewski, JP; Fensterl, J; Bailey, L; Carew, JS; Foster, B; Rush, ML; Adams, D; Griffiths, EA; Sekeres, MA
Published Date
- December 3, 2015
Published In
Volume / Issue
- 126 / 23
Published By
Pages
- 3
Electronic International Standard Serial Number (EISSN)
- 1528-0020
International Standard Serial Number (ISSN)
- 0006-4971
Conference Name
- 57th Annual Meeting of the American-Society-of-Hematology
Conference Location
- Orlando, FL
Conference Start Date
- December 5, 2015
Conference End Date
- December 8, 2015